RIAMB (Beijing) Technology Development Co (603082) Fair Value & Analysis
Industrials · CN · Market cap 5.5B CNY
Analysis
RIAMB (Beijing) Technology Development Co (603082) currently trades at ¥45.13, while our model-based Fair Value estimate is ¥20.40 — implying the stock looks roughly 54.8% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
RIAMB (Beijing) Technology Development Co., Ltd. Is involved in the research, design, development, and manufacturing of intelligent logistics systems in China and internationally. The company offers stacker, conveyor, EMS, shuttle, robot, automatic sorting, automatic guided trolley, special logistics equipment, and computer monitoring management systems. It also provides intelligent logistics system solutions for fiber manufacturing industry; cold chain logistics automation solutions; shuttle intelligent warehousing solutions; and goods-to-person picking system solutions. In addition, the company offers planning and design, equipment customization, software control system development installation and commissioning, system integration, and customer training. It exports its products. The company serves manufacturing, medicine, food, fiber manufacturing, home furnishing, petrochemical, financial, and other industries. RIAMB (Beijing) Technology Development Co., Ltd. was founded in 1954…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.